UNIVERSITY OF ALABAMA AT BIRMINGHAM
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2014-11-27
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT00240097
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
Pediatric Epilepsy Database
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-04-19
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00204360
- Locations
- ๐บ๐ธ
Children's Hospital of Alabama, Birmingham, Alabama, United States
Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 20
- Registration Number
- NCT00204347
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
Risperidone and Suicidality in Major Depressive Disorder
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 30
- Registration Number
- NCT00167154
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2011-01-04
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 28
- Registration Number
- NCT00161291
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00137358
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
To Examine Smoking Behavior of Prisoners - 1
Completed
- Conditions
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 360
- Registration Number
- NCT00115674
- Locations
- ๐บ๐ธ
Virginia Commonwealth University, Richmond, Virginia, United States
Comparison of School-Based Supervised Versus Parental Supervised Asthma Therapy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-05-09
- Last Posted Date
- 2014-03-04
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 295
- Registration Number
- NCT00110383
- Locations
- ๐บ๐ธ
University of Alabama Birmingham Lung Health Center, Birmingham, Alabama, United States
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 31
- Registration Number
- NCT00096343
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2013-04-12
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 50
- Registration Number
- NCT00004184
ยฉ Copyright 2024. All Rights Reserved by MedPath